Clinical Trials on Locally Advanced Neuroendocrine Neoplasm in Japan
Total 312 results
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Millennium Pharmaceuticals, Inc.TerminatedSmall Cell Lung Cancer | Ovarian Cancer | Advanced Solid TumorsJapan, Korea, Republic of
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Genentech, Inc.Active, not recruitingAdvanced/Metastatic TumorsSpain, United States, Korea, Republic of, Australia, France, Japan, Canada
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
Takara Bio Inc.CompletedMelanoma Stage IV | Melanoma Stage IIIJapan
-
AstraZenecaActive, not recruitingPart1: Advanced B-cell Malignancies | Part2: r/rCLL and r/rMCL | Part3: Untreated CLLJapan
-
AstraZenecaCompletedAdvanced Solid TumorsJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Novartis PharmaceuticalsActive, not recruiting
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan, Finland
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan, Denmark
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Turkey, United Kingdom, Switzerland, Italy
-
Taiho Pharmaceutical Co., Ltd.RecruitingGastric Cancer | Colorectal Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Alveolar Soft Part Sarcoma | Advanced or Metastatic Solid TumorJapan
-
PfizerCompleted
-
TakedaCompletedAdvanced Hepatocellular CarcinomaJapan
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Taiwan, China, Korea, Republic of, Poland, Italy, Spain, Australia, Brazil, Argentina
-
AmgenCompletedUnresectable Stage IIIB-IV Malignant MelanomaJapan
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, China, Croatia, Japan, Latvia, Poland, Brazil, Lithuania, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced or Metastatic Solid TumorsChile, Hungary, Korea, Republic of, South Africa, Spain, Japan
-
AmgenRecruitingAdvanced Solid TumorsTaiwan, Australia, United States, Japan, Korea, Republic of, Poland
-
Merck Sharp & Dohme LLCRecruitingVon Hippel-Lindau Disease | Pancreatic Neuroendocrine Tumor | Pheochromocytoma/Paraganglioma | Advanced Gastrointestinal Stromal Tumor | HIF-2α Mutated CancersCanada, United States, Denmark, France, Germany, Hungary, Italy, Russian Federation, Spain, Sweden, Turkey, Israel, United Kingdom, Netherlands, Australia, China, Singapore, Japan
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Ministry of Health, Labour and Welfare, JapanUnknownNeoplasms | Carcinoma | Carcinoma, Hepatocellular | Liver Neoplasms | Advanced Hepatocellular CarcinomaJapan
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesTaiwan, Netherlands, Italy, Korea, Republic of, Japan, United States, Switzerland, Canada, Singapore
-
Novartis PharmaceuticalsTerminatedAdvanced Gastric CancerSpain, Belgium, France, Italy, United States, Korea, Republic of, Japan, Germany
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
PfizerCompletedAdvanced Renal Cell CarcinomaKorea, Republic of, Japan, China
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAdvanced Lymphoid LeukemiaUnited States, United Kingdom, Japan, France, Spain
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumor CancerUnited States, Korea, Republic of, Spain, Israel, Japan, France
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan